GenoVive Launches in Mexico;
Announces Partnership with Mexico City’s Bariatric Support to Bring DNA-based Weight Loss Solutions to Latin America
NEW ORLEANS (June 4, 2012) – GenoVive, a pioneer in DNA-based, all-natural weight management solutions, today announced the company’s first international partnership with Bariatric Support, one of Mexico City’s leading bariatric support centers that offers a multi-disciplinary approach to prevention, wellness and weight loss. The partnership brings GenoVive’s innovative approach to weight loss to Mexico, including the use of DNA testing that identifies an individual’s unique genetic make-up that is the basis for customized meals and exercise plans to optimize weight loss and encourage long-term weight management.
As people in the United States and around the world continue to realize the harmful effects of obesity, GenoVive remains committed to the continued development of a long-term and comprehensive solution to weight management based on individual genetics and personalized nutrition and exercise. The company was founded to exploit the emerging field of nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in weight gain.
GenoVive’s partnership with Bariatric Support will also allow for further research into how different cultures and ethnicity affect weight gain, loss and management. In fact, Mexico has the second highest incidence of obesity topped only by the United States.
“Bariatric Support is the ideal partner to launch GenoVive’s breakthrough weight management science outside of the United States,” said Vic Castellon, founder and CEO, GenoVive LLC. “Bariatric Support enjoys a solid reputation in Mexico City as a leader in weight loss programs. They have an active base of individuals who desire to lose weight in a healthy manner by getting to the root of their weight management challenges through meals and exercise programs developed specifically for their genetic profile. GenoVive remains committed to growing its program in the United States, and now internationally through this initial partnership in Mexico.”
“GenoVive’s innovative approach to weight loss based on DNA analysis and all-natural meal programs has already resonated tremendously with our patients in Mexico City,” said Tatiana Palazuelos, nutritionist with Bariatric Support. “GenoVive’s program complements our holistic and comprehensive approach to weight loss which includes physician visits and oversight plus nutrition and psychological counseling. We look forward to growing the partnership to benefit our patient base who desire customized weight loss programs that will work for the long term.”
GenoVive’s program starts with an easy-to-use, in-home DNA test. GenoVive analyzes the results and designs ideal weight management programs with home-delivered meals based on optimum fats, carbohydrates, proteins, plus exercise that works best with an individual’s personal genetic makeup to increase the chances for long-term weight management. Each meal has been created with an optimal balance of macronutrients, vitamins and minerals, and at calorie levels that support healthy and sustainable weight loss.
Because food carries information to genes about the environment and serve as signals to our surrounding cells and can change the expression of certain genes, GenoVive is one of the only national weight management companies to offer meals that contain no growth hormones, antibiotics, preservatives, nitrates, sulfites, artificial sweeteners or sugar alcohols, or other similar incidental ingredients that may not be required to appear on the label.
“We understand obesity’s multifactorial causation including lifestyle, eating patterns, psychological disorders, metabolic influence of our patients,” said Denise Arcila, lead psychologist at Bariatric Support. “GenoVive complements and completes our multidisciplinary approach and is is the only weight management option in Mexico to offer all-natural meals designed for our patients’ unique genetic profiles. GenoVive is an easy and effective tool for our patients to learn about portion control while eating nutritionally balanced, all-natural meals which will help them control their weight and health over the long run.”
Claudia Gonzales, founder and dietician, Bariatric Support, who has been working with obesity patients for nearly 15 years, is already seeing results from patients on the GenoVive plan. “The ability to customize our patients’ meals based on their specific genes helps them see results faster and encourages them to make even more lifestyle changes that lead to sustainable weight loss.”
Hold the Butylated Hydroxyanisole: Genovive Survey Reveals Adults Prefer Diet Food Without a Side Order of Preservatives
NEW ORLEANS (March 26, 2012) -- Americans looking to lose weight want diet food companies to hold the preservatives according to a recent survey conducted by Harris Interactive on behalf of GenoVive, a new weight management program that uses genetic analysis as the foundation of customized weight loss programs. The January survey of more than 2,500 adults ages 18 and older found that two out of three people surveyed (67%) would prefer that their diet foods include only all-natural ingredients without preservatives and not processed foods with other potentially harmful chemicals and additives.
“Additives such as preservatives, antibiotics, hormones, and a variety of new-to-nature components appear to negatively impact the quality of our food and potentially negatively impact our bodies,” said Dr. Ruth DeBusk, PhD, RD, who is a geneticist, molecular biologist and clinical dietitian in practice in Tallahassee, Florida, and a member of GenoVive’s Scientific Advisory Board.
The survey also showed that women are significantly more likely than men to prefer diet foods with all natural ingredients, with 71% of women making this choice over 63% of men.
“With women making many of the critical decisions about food in American households, it comes as no surprise that women in particular are demanding better ingredients for their diet needs and overall food choices for their families,” said Dr. DeBusk. “Diet foods that are laden with additives actually work against us by disrupting the body’s natural tendencies. They make the challenge of losing weight and keeping it off even more difficult.”
Beverly Swango, nutritionist and director of product development at GenoVive, cautions against the proliferation of food additives in the foods we eat that exceed reasonable amounts each day.
“It’s unfortunate, but today, most diet foods as well as a startling number of food items found in our supermarkets contain additives and chemicals that trigger unwanted reactions in our cells and in our genes,” said Swango.
According to Swango, most consumers realize that the BPA found in water bottles is harmful yet some of the most-unsuspecting foods also contain additives. “Tortilla wraps contain anti-microbials while nutrient bars for diabetics include titanium dioxide. While some additives are considered safe in trace amounts, over time there can be cumulative effect that can have significant negative impact on consumer health. At GenoVive, we only use ‘real food’ that the body was designed to metabolize.”
About GenoVive LLC
Founded in 2008, GenoVive, a division of Genvis Bio Group, LLC, based in New Orleans, LA, represents a new approach to weight loss and sustained healthy eating. GenoVive’s geneticists and food scientists developed customized, all-natural meal and exercise programs, featuring ideal combinations of macronutrients based on individual DNA. GenoVive is sold directly to the consumer at GenoVive.com and by phone with convenient home delivery. Follow GenoVive on Twitter @myGenovive, Facebook at www.facebook.com/GenoVive, and YouTube at www.youtube.com/GenoVivednadiet.
# # #
GenoVive Expands Scientific Advisory Board, Adds Prominent Experts in Nutrigenomics and Exercise Physiology
Appointments Round Out World-Class Advisory Board of Pioneering Weight Management Company
NEW ORLEANS, LA--(Mar 6, 2012) - GenoVive, a pioneer in DNA-based, all-natural weight management solutions, today announced that Dr. Ruth DeBusk, PhD, RD, and Dr. Barbara E. Ainsworth, PhD, MPH, FACSM, FNAK, have joined the company's Scientific Advisory Board, advising on the integration of nutrition and exercise into the innovative and all-natural weight management program based on genetic science.
Dr. Ainsworth is a professor in the Exercise and Wellness Program within the School of Nutrition and Health Promotion at Arizona State University, and a fellow in the American College of Sports Medicine (ACSM), the National Academy of Kinesiology, the Research Consortium of American Alliance for Health, Physical Education, Recreation and Dance, and the North American Society of Health, Physical Education, Recreation and Dance Professionals. Dr. Ainsworth holds an honorary academic appointment at the Akershus University College in Oslo, Norway, has served as President for the ACSM and was a 2006 ACSM Citation Award recipient. Her ongoing research relates to physical activity and public health with a focus on the assessment of physical activity in populations. She has authored more than 250 publications and is the lead author for the Compendium of Physical Activities.
Dr. DeBusk is a geneticist and clinical dietician in practice in Tallahassee, Florida. Trained first as a food and nutrition professional and subsequently as a geneticist and molecular biologist, Dr. DeBusk has been a member of the genetics faculty at Florida State University for many years. Her research combines nutrition and genetics, focusing on genetic regulation of nutrient absorption in response to environmental signals. She has served on local, state, national and international committees and advisory boards related to nutrition, genetics and biotechnology, is an author of several books, including the American Dietetic Association's Genetics: The Nutrition Connection. Her many awards include the Florida Dietetic Association's 2009 Outstanding Dietician Award, and the 2007 Harold Harper Award for Science and Practice by the American College for the Advancement in Medicine.
"Dr. Ainsworth and Dr. DeBusk are both exceedingly respected in their fields for their deep expertise and practical experience, and their membership on the GenoVive Scientific Advisory Board is an outstanding addition to our team of leaders in the fields of genetics, nutrition and exercise physiology," said Vic Castellon, founder and CEO, GenoVive LLC. "As Americans continue to battle the overweight and obesity epidemic, GenoVive remains committed to the continued development of a long-term and comprehensive solution to weight management based on individual genetics and personalized nutrition and exercise through collaboration with our Scientific Advisory Board members," Castellon added.
The GenoVive Scientific Advisory Board was established to guide the company's research activities, seeking out the most innovative and promising research projects for continuing validation of the emerging field of nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in weight gain.
"Combining gene-informed diets and physical activity protocols to address weight management and metabolic health is the scientific foundation for personalized lifestyle medicine," said Dr. Ainsworth. "Not only does the application of nutrigenomics inform dietary choices, understanding individual differences in responsiveness to exercise protocols provide a roadmap for metabolic health and effective weight control."
"Our personal health continuum is influenced by our daily diet and lifestyle choices and those choices interact with our genes throughout our lifetime," said Dr. DeBusk. "Advances in understanding the role of genes in health and disease and that food is powerful information for our genes has made us keenly aware of the importance of knowing what's in our genetic makeup and being able to match our diet and lifestyle choices to our genetic potential."
About GenoVive LLC
Founded in 2008, GenoVive, a division of Genvis Bio Group, LLC, based in New Orleans, LA, represents a new approach to weight loss and sustained healthy eating. GenoVive's geneticists and food scientists developed customized, all-natural meal and exercise programs, featuring ideal combinations of macronutrients based on individual DNA. GenoVive is sold directly to the consumer at GenoVive.com and by phone with convenient home delivery. Follow GenoVive on Twitter @myGenovive, Facebook, and YouTube.
National Survey Reveals Americans' Lack of Faith in Celebrity-Endorsed Diets
Americans Trust Scientific Approach to Weight Loss and Customized Diets Based on Individual DNA According to Study by Pioneering Web Management Company, GenoVive; Extreme Optimism About Current Diet Methods May Be a Factor in Rising Obesity Rates.
NEW ORLEANS (Feb. 1, 2012) A survey of more than 2,500 U.S. adults reveals that nearly 79 percent of Americans do not believe that celebrity-fad diets work for everyone. The study was conducted online in early January 2012 by Harris Interactive on behalf of GenoVive, a weight management solution rooted in DNA science that uses genetic analysis as the foundation of weight loss programs. The survey shows that Americans are skeptical of celebrity-fad diets because they are not designed to focus on an individual’s specific genetic predisposition to gaining or losing weight. The survey also points to the majority being optimistic about their weight loss success, which may be a contributing factor to spiraling obesity rates in the United States.
More U.S. women than men indicated that they do not think they work with 81 percent of women versus 77 percent of men not trusting celebrity-endorsed fad diets. Moreover, older Americans are significantly more likely to say this than their younger counterparts with 82 percent of adults over age 55 believing celebrity-fad diets do not work compared to 76 percent of those between the ages of 18 and 34, and 77 percent of those aged 35 to 44 years.
“While Americans feel optimistic at the start of their diets, the staggering rates of obesity in our country belies their perceived success,” said Dr. David Katz MD, MPH, FACPM, FACP, the founding director of Yale University’s Prevention Research Center, and member of GenoVive’s Scientific Advisory Board. “People start off with the best intentions, but the diets and the diets foods themselves may be setting them up for failure in the long run. Some diets may leave bodies in worse states than before they were started.”
The survey also examined the extreme optimism about conventional diets, which may be a contributing factor in increasing obesity rates in the United States. Eighty-two percent of U.S. adults who are currently on a diet or plan to go on a diet in 2012 believe they will be successful in following their current/future diet plan. However, nearly two-thirds or 65 percent of U.S. adults indicate they have ever faced any challenges while dieting (i.e., trying to lose weight). Furthermore, 86 percent of those who have ever been on a diet feel their expectations are not too high.
According the survey, more than 1 in 5 U.S. adults, or 21 percent, who have ever been on a diet indicate that their genetic predispositions such as DNA, body type or metabolism, is the biggest challenge they have ever faced when trying to lose weight. For those that do find weight loss success, one of the biggest challenges they face is keeping the weight off. Forty-five percent of U.S. adults who have ever been on a diet consider keeping the weight off to be their biggest obstacle to weight loss success.
GenoVive Announces Formation of Scientific Advisory Board
Key Appointments Include Doctors and Experts in the Health and Weight Management Fields from Yale University and the University of North Carolina Who Will Provide Critical Scientific Input and Strategic Insight
NEW ORLEANS (Jan. 9, 2012) – GenoVive, a pioneer in DNA-based, all-natural weight management solutions, today announced the formation of a scientific advisory board (SAB) comprised of prominent, multi-disciplinary experts in the fields of health and weight management, nutrigenomics, genetics, biochemistry, clinical psychology, and food science.
The three initial SAB appointments include Dr. Steven H. Zeisel, MD, PhD, Dr. David Katz, MD, MPH, FACPM, FACP, and Dr. Daniel Pomp, MS, PhD, who will guide research activities and provide critical scientific input and strategic insight to GenoVive as the company continues to exploit and leverage current scientific breakthroughs to deliver a comprehensive and personalized weight management solution based on genetic science.
“We are privileged to have these three respected and prominent experts who will help guide our research and lend their specific expertise that will enable us to delve deeper in to the emerging advances of nutritional science and personalized health to bring the best possible weight management solutions to the millions of Americans who are overweight,” said Vic Castellon, founder and CEO, GenoVive LLC.
The GenoVive SAB was established to guide the company’s research activities, seeking out the most innovative and promising research projects for continuing validation of the emerging field of nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in weight gain. The board will also guide the translation of published science into actionable solutions and explore ways to expand its research efforts to accelerate the development of new innovative products.
“Though we once thought that everyone was metabolically the same, we now are learning that there is a great deal of variation in metabolism, much of which is explained by misspellings in our genetic code,” said Dr. Steven Zeisel, who serves as the Director of the Nutrition Research Center at the University of North Carolina. “As the director of a major academic research center that focuses on this specific research, this new science makes it possible to individualize our approach to nutrition. GenoVive is one of the first companies to use this science to improve our treatment of overweight and obesity.”
According to Dr. David Katz, the basic theme of healthful, sensible eating, and sensible approaches to weight control is not up for debate, but the best variation on that theme for an individual is. “We know that genetic variants influence metabolism with important implications for weight control,” said Dr. Katz. “Basing customized weight management approaches on genetic insights is an idea whose time has come. Doing so in a manner that fully respects the fundamentals of healthful eating is responsive to the needs of those frustrated by their weight control struggles and responsible about the use of available science.”
Dr. Pomp adds, “We now know that even our voluntary exercise levels, and how people’s bodies respond to exercise in terms of fat loss and muscle gain, are significantly determined by differences in our genetic code, by variations in our DNA. Personalized nutrition and physical activity plans may be important factors in harmonizing an individual’s diet and exercise for improved health and well being.”
The GenoVive Scientific Advisory Board Members include:
Steven H. Zeisel, MD, PhD – Chairman: Dr. Steven Zeisel is the Kenan Distinguished University Professor in the Department of Nutrition in the Gillings School of Global Public Health at the University of North Carolina (UNC) at Chapel Hill. He served as chair of the Department of Nutrition at UNC from 1990-2005. He is currently a member of the American Society for Nutrition, the American Society for Parenteral and Enteral Nutrition, the American College of Nutrition and the Society for Pediatric Research.
Dr. Zeisel is also the Director of the UNC Nutrition Research Institute at the newly formed North Carolina Research Campus in Kannapolis, North Carolina. The Institute is also known as a “metabolic chamber” where researchers study foods, activity levels and genes affecting human metabolism. Their findings will help recommend customized diets and exercise plans that support the ultimate goal of individualized nutrition. The Institute’s research endeavors were recently featured in The Charlotte Observer.
He serves on the Federation of American Societies for Experimental Biology (FASEB) Journal editorial board and is a former member of the Annual Review of Nutrition editorial committee. Dr. Zeisel is a member of the World Cancer Research Fund’s Expert Panel on “Food, Nutrition and the Prevention of Cancer: a Global Perspective.” He serves as the principal investigator on multiple federally funded research projects that focus on human requirements for choline and the effects of this nutrient on brain development. He has authored more than 280 scientific publications.
Dr. Zeisel earned his MD from Harvard Medical School in 1975, was a resident in pediatrics at Yale University from 1975–1977, and earned his PhD in nutrition at the Massachusetts Institute of Technology in 1980.
David L. Katz, MD, MPH, FACPM, FACP: Dr. David Katz is the founding director of Yale University’s Prevention Research Center. He received his BA from Dartmouth College (1984; Magna Cum Laude); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He is a board certified specialist in Preventive Medicine/Public Health, and two-time Diplomate of the American Board of Internal Medicine (1991; 2001). Katz is Director and founder of the Integrative Medicine Center at Griffin Hospital (2000) in Derby, CT, and founder and president of the non-profit Turn the Tide Foundation (www.turnthetidefoundation.org).
Known internationally for expertise in nutrition, weight management, and chronic disease prevention, as well as integrative care and patient-centered care models, Katz is active in patient care, research, teaching, and public health practice. He established, and formerly directed, one of the nation’s first combined residency programs in Internal Medicine and Preventive Medicine; and served as Director of Medical Studies in Public Health at the Yale School of Medicine for eight years.
Katz has secured nearly $35 million in research funding. He has published over 120 scientific articles & textbook chapters; nearly a thousand newspaper columns; innumerable commentaries and blogs; and 12 books to date. He has consulted on obesity control and chronic disease prevention to the World Health Organization; National Cancer Institute; National Governors Association; Health Canada; the Health Ministry of Israel; the Institute of Medicine; several U.S. Governors; the US Secretary of Health; and the FDA.
Dr. Katz serves as a reviewer of federal research grants for the NIH, the CDC, and AHRQ, as well as a number of international organizations. He is a peer reviewer for numerous leading medical journals. He is on the editorial advisory boards of The American Journal of Health Promotion; Prevention Magazine; Health; Men’s Health; Children’s Health; and Eating Well. In 2011, he was appointed Editor-in-Chief of the peer-reviewed journal, Childhood Obesity. He was nominated for the position of US Surgeon General in 2009 by the American College of Physicians, the American College of Preventive Medicine, and the Center for Science in the Public Interest, among others; and was the 2011 recipient of the Katharine Boucot Sturgis award from the American College of Preventive Medicine, the most prestigious award the College confers – awarded for illustrious career contributions to the field of Preventive Medicine. Also in 2011, he received the Lenna Frances Cooper Award from the American Dietetic Association for illustrious contributions to the field of nutrition. In 2012, Katz was named the first inductee into the MDPA Communicating Childhood Obesity Prevention and Policy Hall of Fame.
Daniel Pomp, MS, PhD: Dr. Daniel Pomp is a Professor of Genetics, Nutrition, & Cell and Molecular Physiology in the School of Medicine and the Gillings School of Global Public Health at the University of North Carolina. He is a member of UNC’s Nutrition and Obesity Research Center, Carolina Center for Genome Science, Center for Integrated Systems Genomics, Lineberger Comprehensive Cancer Center, and Center for Environmental Health and Susceptibility.
Dr. Pomp studies the genetic architecture of complex traits, with an emphasis on obesity and body weight regulation. Using polygenic mouse models and high throughput approaches integrating genomics and physiology, he identifies genes that control predisposition to obesity, including components of energy balance such as caloric intake, basal metabolism and voluntary exercise. He studies how these genes interact with each other and with nutritional and therapeutic interventions, and how these combine to regulate an individual’s change in weight, fat and muscle content. Dr. Pomp also investigates polygenic and dietary obesity as risk factors for mammary and colon cancer susceptibility.
Dr. Pomp serves on the editorial board for several journals, including Physiological Genomics, Journal of Biomedicine and Biotechnology, Advances in Genomics and Gene Expression, and Mammalian Genome. Dr. Pomp’s research has been funded by the National Institute of Health, the National Science Foundation, the United States Department of Agriculture, and by a variety of sources in the biomedical and agricultural industries.
He earned his Ph.D. in Animal Genetics from North Carolina State University, a Masters in Animal Breeding from the University of Wisconsin, and a BS in Animal Science from the Hebrew University of Jerusalem.
About GenoVive LLC
Founded in 2008, GenoVive, a division of Genvis Bio Group, LLC, based in New Orleans, LA, represents a new approach to weight loss and sustained healthy eating. GenoVive’s geneticists and food scientists developed customized, all-natural meal and exercise programs, featuring ideal combinations of macronutrients based on individual DNA. GenoVive’s flavorful and quality meals are made without additives and preservatives and consist of six days per week of daily meals including breakfast, lunch, dinner, snacks, beverages, and vitamin supplements. GenoVive is sold directly to the consumer at GenoVive.com and by phone with convenient home delivery. Follow GenoVive on Twitter @myGenovive, Facebook at www.facebook.com/GenoVive, and YouTube at www.youtube.com/GenoVivednadiet.
# # #
Rooted in DNA Science, GenoVive’s
“New Year, New You” Program Takes Aim on America’s Obesity Epidemic
New Research Shows Diets Must Address DNA Differences for Best Outcomes; All-Natural Meals Aid Weight Loss
NEW ORLEANS (Dec. 22, 2011) – As medical research continues to uncover the connection between DNA and weight loss, GenoVive, a pioneer in DNA-based diet solutions, has launched an introductory program aimed at helping Americans jumpstart their weight loss programs as the new year begins.
The “New Year, New You” program represents a modern approach to weight loss that starts with DNA testing and analysis and results in customized meal and exercise plans with online support and nutritional supplements that together lead to healthy and sustainable weight loss.
“Weight management is the outcome of the balance between energy consumption and energy utilization, which is ultimately influenced by individual genes and genetic variation,” said San San Ng, PhD, Molecular Biology (ASCPCM), and Director of Scientific Affairs for GenoVive. “Current research shows that fad, one-size-fits-all or elimination diets that are not based on individual DNA analysis will not deliver optimal results for all people. Weight management programs that feature the ideal combinations of macronutrients and exercise regimens for specific genotypes, teach people how their individual bodies respond to certain foods. And that, in the end, leads to healthier and more sustainable weight loss.”
A member of GenoVive’s Scientific Advisory Board, Dr. Ng’s research interest is in an emerging field in nutrition called nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in weight gain. GenoVive’s “New Year, New You” program is rooted in this science and starts with an in-depth analysis of an individual’s DNA to determine that person’s specific genetic disposition for weight gain including how the body processes and mobilizes fat, metabolizes sugars and carbohydrates and responds to various levels of exercise. Based on the results of the DNA test, GenoVive develops meal and exercise programs that are customized to work for that person’s unique genetic makeup.
According to GenoVive founder, Vic Castellon, a pharmacist with a background in DNA sciences, some individuals are genetically predisposed to gain weight more easily than others, resist or regain weight loss, store weight in the abdominal area, or any combination of these outcomes.
“Our geneticists reviewed more than 2,000 studies on the impact of genes on weight loss and identified 12 gene variants that are key to sustained weight loss,” said Castellon. “A weight management program that is based on individual genetic profiles dramatically increases the chances for healthy weight loss success over the long-term.”
Recent research also illustrates how food additives, preservatives and hormones disrupt cell function and hinder weight loss. Because food carries information to our genes about the environment, they serve as signals to our surrounding cells and can change the expression of certain genes. Unlike other major weight loss programs, all food in the GenoVive programs is 100 percent natural and does not contain:
The “New Year, New You” program will be offered for a limited time only. For $599.98, or less than $20 per day, the weight loss solution includes:
GenoVive is sold directly to the consumer through GenoVive.com and by phone with convenient home delivery. For more information, visit GenoVive on Twitter @myGenovive, Facebook at www.facebook.com/GenoVive, and YouTube at www.youtube.com/GenoVivednadiet.